Seattle’s biotech industry has endured what could be called a lost decade after a number of the brightest stars of the 1990s—Immunex, Icos, Rosetta Inpharmatics, Corixa—were acquired by companies in other places that made local cutbacks. But a number of today’s Northwest biotechs, particularly Dendreon and Seattle Genetics, are emerging as globally competitive players, while potential blockbuster drug and vaccine candidates are also emerging at small startups like Alder Biopharmaceuticals, Calistoga Pharmaceuticals, and Immune Design. What needs to happen for Seattle to sustain this newfound momentum, and continue making a global impact on the life sciences industry over the coming decades?
Keynote: State of Northwest Biotech
Mitchell Gold, CEO, Dendreon
Luke Timmerman (moderator), National Biotechnology Editor, Xconomy
Mitchell Gold, CEO, Dendreon
Clay Siegall, CEO, Seattle Genetics
Carol Gallagher, CEO, Calistoga Pharmaceuticals
Randy Schatzman, CEO, Alder Biopharmaceuticals
Burst Presentations: Health Innovations With Global Impact
Caitlin Cameron, CEO, Presage Biosciences
Tom Hansen, CEO, Seattle Children's Hospital
Stefan Kappe, Associate, Seattle Biomedical Research Institute
Ryo Kubota, CEO, Acucela
Explore the inner workings of PATH’s Product Development Shop and Research Laboratory. Expert global health staff will provide a brief overview of this unique setting for advancing health technologies, point of care diagnostics, and spray-dried vaccines that are destined for the world’s poorest regions. A tour will be given at 5:00. RSVP to firstname.lastname@example.org.
Tours: 4:30 and 5:00 pm
Registration: 5:15 – 6:00 pm
Program: 6:00 – 7:30 pm
Networking reception: 7:30 – 8:30 pm
Tickets are transferable but not refundable.
To inquire about press registration, email email@example.com.
Alexandria Real Estate Equities • AMRI • Christensen O'Connor Johnson Kindness
Cooley • Davis Wright Tremaine • Fenwick & West • Institute for Systems Biology
Invest Northern Ireland • J. Robert Scott • Kauffman Foundation
Science and Technology Directorate, U.S. Department of Homeland Security
Seed IP • Swedish Medical Center • Wells Fargo Insurance Services
VENTURE CAPITAL MEMBERS
ARCH Venture Partners · Vulcan Capital ·WRF Capital
Alliance of Angels • Evergreen Venture Capital Association
Northwest Entrepreneur Network • Technology Alliance
Washington Biotechnology & Biomedical Association
Washington Technology Industry Association
When & Where
Xconomy is an innovative news and events organization with outposts in Boston, Boulder/Denver, Detroit/Ann Arbor, New York, Raleigh-Durham, San Diego, San Francisco, Seattle, Texas, and Wisconsin. It is dedicated to providing business and technology leaders with timely, insightful, close-to-the-scene information about the local personalities, companies, and technological trends that best exemplify today’s high-tech economy. Xconomy is staffed by world-class journalists and media professionals, and supported by “the Xconomists,” who include some of the world’s leading innovators. Get to know them and the Xconomy team at www.xconomy.com/about.
Sign up for RSS feeds, daily email newsletters, and email alerts from Xconomy at http://www.xconomy.com/rss-feeds/.